CSRC website shows Fengshi (Qingdao) Marine Technology Co., Ltd. formally began
IPO counseling on Sept. 28, 2026, with Guosen Securities appointed as the
counselor. The Qingdao-based company develops marine pharmaceuticals and
bioproducts, primarily utilizing Antarctic krill.